Cargando…
A comparative study of propofol alone and propofol combined with midazolam for dental treatments in special needs patients
Although dental treatment with sedation is performed increasingly in special needs patients, data on adding midazolam to intravenous propofol sedation are very limited for this group. The purpose of this study was to identify the factors and procedure time associated with the use of intravenous seda...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183838/ https://www.ncbi.nlm.nih.gov/pubmed/34087890 http://dx.doi.org/10.1097/MD.0000000000026199 |
_version_ | 1783704455706836992 |
---|---|
author | Lin, I-Hsin Huang, Mao-Suan Wang, Pei-Yu Huang, Ta-Sen Chong, See-Yen Chen, Sam Li-Sheng Tsai, Hung-Huey |
author_facet | Lin, I-Hsin Huang, Mao-Suan Wang, Pei-Yu Huang, Ta-Sen Chong, See-Yen Chen, Sam Li-Sheng Tsai, Hung-Huey |
author_sort | Lin, I-Hsin |
collection | PubMed |
description | Although dental treatment with sedation is performed increasingly in special needs patients, data on adding midazolam to intravenous propofol sedation are very limited for this group. The purpose of this study was to identify the factors and procedure time associated with the use of intravenous sedation with propofol alone or propofol combined with midazolam in dental patients with special needs. This was a retrospective data analysis. The sedation medications and relevant covariates, including demographic parameters, disability levels, oral health conditions, dental procedures, treatment time, and side effects, of 718 patients with special needs were collected between April 2013 and September 2014. The unfavorable side effects by sedation types were reported. Factors associated with procedure time and the sedation medications were assessed with multiple logistic regression analyses. Of 718 patients, 8 patients experienced unfavorable side effects (vomiting, sleepiness, or emotional disturbance) after the dental procedures; the rate was 0.6% in the 509 patients who received propofol only. In 209 patients who received propofol and midazolam, 2.4% experienced the side effects. Sedation time was associated with body mass index (BMI) < 25 (adjusted odds ratio [aOR] = 1.45, 95% confidence interval [CI]: 1.04–2.04) and the performance of multiple dental procedures (aOR = 1.44, 95% CI: 1.06–1.97) but not associated with the sedation types. A significant odds ratio for the combined use of propofol and midazolam was shown for adolescents (aOR = 2.22, 95% CI: 1.28–3.86), men (aOR = 2.05, 95% CI: 1.41–2.98), patients with cognitive impairment (aOR = 1.99, 95% CI: 1.21–3.29), and patients undergoing scaling procedures (aOR = 1.64, 95% CI: 1.13–2.39). With the acceptable side effects of the use of propofol alone and propofol combined with midazolam, multiple dental procedures increase the sedation time and the factors associated with the combined use of propofol and midazolam are younger age, male sex, recognition problems, and the type dental procedure in the dental treatment of patients with special needs. |
format | Online Article Text |
id | pubmed-8183838 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-81838382021-06-07 A comparative study of propofol alone and propofol combined with midazolam for dental treatments in special needs patients Lin, I-Hsin Huang, Mao-Suan Wang, Pei-Yu Huang, Ta-Sen Chong, See-Yen Chen, Sam Li-Sheng Tsai, Hung-Huey Medicine (Baltimore) 3300 Although dental treatment with sedation is performed increasingly in special needs patients, data on adding midazolam to intravenous propofol sedation are very limited for this group. The purpose of this study was to identify the factors and procedure time associated with the use of intravenous sedation with propofol alone or propofol combined with midazolam in dental patients with special needs. This was a retrospective data analysis. The sedation medications and relevant covariates, including demographic parameters, disability levels, oral health conditions, dental procedures, treatment time, and side effects, of 718 patients with special needs were collected between April 2013 and September 2014. The unfavorable side effects by sedation types were reported. Factors associated with procedure time and the sedation medications were assessed with multiple logistic regression analyses. Of 718 patients, 8 patients experienced unfavorable side effects (vomiting, sleepiness, or emotional disturbance) after the dental procedures; the rate was 0.6% in the 509 patients who received propofol only. In 209 patients who received propofol and midazolam, 2.4% experienced the side effects. Sedation time was associated with body mass index (BMI) < 25 (adjusted odds ratio [aOR] = 1.45, 95% confidence interval [CI]: 1.04–2.04) and the performance of multiple dental procedures (aOR = 1.44, 95% CI: 1.06–1.97) but not associated with the sedation types. A significant odds ratio for the combined use of propofol and midazolam was shown for adolescents (aOR = 2.22, 95% CI: 1.28–3.86), men (aOR = 2.05, 95% CI: 1.41–2.98), patients with cognitive impairment (aOR = 1.99, 95% CI: 1.21–3.29), and patients undergoing scaling procedures (aOR = 1.64, 95% CI: 1.13–2.39). With the acceptable side effects of the use of propofol alone and propofol combined with midazolam, multiple dental procedures increase the sedation time and the factors associated with the combined use of propofol and midazolam are younger age, male sex, recognition problems, and the type dental procedure in the dental treatment of patients with special needs. Lippincott Williams & Wilkins 2021-06-04 /pmc/articles/PMC8183838/ /pubmed/34087890 http://dx.doi.org/10.1097/MD.0000000000026199 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) |
spellingShingle | 3300 Lin, I-Hsin Huang, Mao-Suan Wang, Pei-Yu Huang, Ta-Sen Chong, See-Yen Chen, Sam Li-Sheng Tsai, Hung-Huey A comparative study of propofol alone and propofol combined with midazolam for dental treatments in special needs patients |
title | A comparative study of propofol alone and propofol combined with midazolam for dental treatments in special needs patients |
title_full | A comparative study of propofol alone and propofol combined with midazolam for dental treatments in special needs patients |
title_fullStr | A comparative study of propofol alone and propofol combined with midazolam for dental treatments in special needs patients |
title_full_unstemmed | A comparative study of propofol alone and propofol combined with midazolam for dental treatments in special needs patients |
title_short | A comparative study of propofol alone and propofol combined with midazolam for dental treatments in special needs patients |
title_sort | comparative study of propofol alone and propofol combined with midazolam for dental treatments in special needs patients |
topic | 3300 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183838/ https://www.ncbi.nlm.nih.gov/pubmed/34087890 http://dx.doi.org/10.1097/MD.0000000000026199 |
work_keys_str_mv | AT linihsin acomparativestudyofpropofolaloneandpropofolcombinedwithmidazolamfordentaltreatmentsinspecialneedspatients AT huangmaosuan acomparativestudyofpropofolaloneandpropofolcombinedwithmidazolamfordentaltreatmentsinspecialneedspatients AT wangpeiyu acomparativestudyofpropofolaloneandpropofolcombinedwithmidazolamfordentaltreatmentsinspecialneedspatients AT huangtasen acomparativestudyofpropofolaloneandpropofolcombinedwithmidazolamfordentaltreatmentsinspecialneedspatients AT chongseeyen acomparativestudyofpropofolaloneandpropofolcombinedwithmidazolamfordentaltreatmentsinspecialneedspatients AT chensamlisheng acomparativestudyofpropofolaloneandpropofolcombinedwithmidazolamfordentaltreatmentsinspecialneedspatients AT tsaihunghuey acomparativestudyofpropofolaloneandpropofolcombinedwithmidazolamfordentaltreatmentsinspecialneedspatients AT linihsin comparativestudyofpropofolaloneandpropofolcombinedwithmidazolamfordentaltreatmentsinspecialneedspatients AT huangmaosuan comparativestudyofpropofolaloneandpropofolcombinedwithmidazolamfordentaltreatmentsinspecialneedspatients AT wangpeiyu comparativestudyofpropofolaloneandpropofolcombinedwithmidazolamfordentaltreatmentsinspecialneedspatients AT huangtasen comparativestudyofpropofolaloneandpropofolcombinedwithmidazolamfordentaltreatmentsinspecialneedspatients AT chongseeyen comparativestudyofpropofolaloneandpropofolcombinedwithmidazolamfordentaltreatmentsinspecialneedspatients AT chensamlisheng comparativestudyofpropofolaloneandpropofolcombinedwithmidazolamfordentaltreatmentsinspecialneedspatients AT tsaihunghuey comparativestudyofpropofolaloneandpropofolcombinedwithmidazolamfordentaltreatmentsinspecialneedspatients |